COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
Sarah Conway, Brian C. Healy, Jonathan Zurawski, Christopher Severson, Tamara Kaplan, Lynn Stazzone, Kristin Galetta, Tanuja Chitnis, Maria K. Houtchens
Topics & Concepts
MedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)Retrospective cohort studyPediatricsInternal medicineMedical recordSeverity of illnessPneumoniaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Young adultComorbidityDiseaseInfectious disease (medical specialty)ImmunologyLong-Term Effects of COVID-19Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders